TrialBritish journal of clinical pharmacology2016

Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus.

Jennifer Witcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.